Lunit Appoints Craig Hadfield as CEO of Volpara, Strengthening AI-Powered Cancer Detection Leadership

27th February, 2025

Hadfield succeeds Dr. Ralph Highnam, who transitions to Chief Science & Innovation Officer, as Volpara accelerates global growth in AI-driven cancer detection and prevention.

Craig Hadfield, newly appointed CEO of Volpara (Courtesy of Lunit)

Craig Hadfield, newly appointed CEO of Volpara (Courtesy of Lunit)

Lunit (KRX: 328130) has announced the appointment of Craig Hadfield as the new CEO of Volpara Health, effective April 1, 2025. Hadfield, currently CFO of Volpara, succeeds Dr. Ralph Highnam, who will transition to Chief Science & Innovation Officer and continue as an Executive Director on the Board.

With over 25 years of financial and operational experience, Hadfield has been instrumental in Volpara’s global expansion and strategic growth. His leadership aims to strengthen Volpara’s position in AI-powered cancer detection and prevention.

“Craig’s expertise and deep understanding of Volpara’s mission make him the ideal leader for our next growth phase,” said Brandon Suh, CEO of Lunit.

The transition aligns with Lunit’s commitment to advancing AI-driven healthcare solutions, reinforcing Volpara’s global impact in early cancer detection and imaging innovation.

Artificial Intelligence Breakthroughs

Robots In Medtech

Asia Pacific

Global / International

© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer